Epigral Limited (BOM:543332)

India · Delayed Price · Currency is INR

1,083.30

+32.25 (3.07%)

At close: Jul 20, 2026

-39.79% (1Y)

Market Cap	46.73B -39.8%
Revenue (ttm)	25.27B -0.9%
Net Income	3.32B -7.2%
EPS	76.95 -9.1%
Shares Out	n/a
PE Ratio	14.08
Forward PE	11.55
Dividend	5.00 (0.48%)
Ex-Dividend Date	Jun 1, 2026

Volume	2,862
Open	1,052.00
Previous Close	1,051.05
Day's Range	1,044.90 - 1,088.30
52-Week Range	806.20 - 2,114.30
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 30, 2026

About Epigral

Epigral Limited manufactures and sells chlor-alkali and derivative products in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resin, epichlorohydrin, chloromethanes value chain, hydrogen peroxide, caustic soda and potash, chlorine, hydrogen, chloromethanes, captive power plant (CPP), and chlorotoluene value chain, as well as operates wind-solar hybrid power plant. Its products are used in CPVC pipes and fittings, windmills, construction, paints and coatings, electronics, water treatment, agrochemicals, pharm... [Read more]

Industry Chemicals and Allied Products

Founded 2007

Employees 1,135

Stock Exchange Bombay Stock Exchange

Ticker Symbol 543332

Full Company Profile

Financial Performance

In fiscal year 2026, Epigral's revenue was 25.27 billion, a decrease of -0.90% compared to the previous year's 25.50 billion. Earnings were 3.32 billion, a decrease of -7.19%.

Financial Statements